Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

NCT01875874 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Due to VTI-208 results, the ELAD clinical plan is being re-evaluated.

Conditions

Acute Liver Failure
Fulminant Hepatic Failure
Primary Graft Non-Function
Surgically-Induced Liver Failure

Interventions

BIOLOGICAL: ELAD

Sponsor

Vital Therapies, Inc.